PaxeraHealth announced that the University of Pennsylvania has selected its zero-coding authoring platform to assist in their development of new imaging AI algorithms. ARK’s offering of “Algorithms as a service” aim to help healthcare systems and academic and research centers to DIY (Do-It-Yourself) their own AI algorithms for all possible modalities, body parts, and anomalies.

May 27, 2022 — PaxeraHealth announced that the University of Pennsylvania has selected its zero-coding authoring platform to assist in their development of new imaging AI algorithms. ARK’s offering of “Algorithms as a service” aim to help healthcare systems and academic and research centers to DIY (Do-It-Yourself) their own AI algorithms for all possible modalities, body parts, and anomalies. UPenn’s ultrasound research lab – Department of Radiology will use the platform to elevate the research and development of their associated imaging laboratories and expedite production of their focused algorithms.

“PaxeraHealth is pleased to offer our zero-coding authoring tools to the help ultrasound research team at UPenn complete the development of their algorithms for the sake of future patients everywhere,” said Dr. Mohamed Shoura, CEO of PaxeraHealth. “We understand the frustrations that come with developing new imaging algorithms and aim to eliminate these with the ARK platform.”

“Aligning UPenn’s research and primary development with Paxera’s high-end tools will expedite our timeline significantly and allow these algorithms to go to market much sooner than estimated”, added Dr. Sandy Sehgal, Professor and Director of ultrasound research at UPenn.

“PaxeraHealth’s ARK platform will be a key element in completing the development of these important algorithms,” added Dr. Laith Sultan, physician scientist at UPenn.

The collaboration between UPenn and Paxera will focus on the development of imaging algorithms to detect liver cancer as well as COVID detection via lung ultrasound. ARK’s high-end modeling, annotation, and data curation tools will reduce development timeline and expedite clinical validation, allowing UPenn to complete and commercialize their new algorithms and make them accessible to PaxeraHealth’s worldwide user base.

For more information: www.paxerahealth.com

 


Related Content

News | Radiopharmaceuticals and Tracers

May 27, 2026 — Subtle Medical has received FDA clearance for its SubtleHD (PET), the company's next-generation AI ...

Time May 27, 2026
arrow
News | FDA

May 19, 2026 — DeepHealth has received the CE Mark for the Brain Health and Brain Age solutions within its Neuro Suite ...

Time May 26, 2026
arrow
News | Cardiac Imaging

May 21, 2026 — A team of researchers from Carnegie Mellon University, in collaboration with Cleveland Clinic’s ...

Time May 22, 2026
arrow
News | X-Ray

May 21, 2026 — RADIN Health and AZmed have announced the expansion of their strategic partnership and enhance radiology ...

Time May 22, 2026
arrow
News | Digital Pathology

May 7, 2026 — Roche has entered into a definitive merger agreement to acquire PathAI, a U.S.-based company in digital ...

Time May 21, 2026
arrow
News | Computed Tomography (CT)

May 12, 2026 – Bracco Imaging S.p.A. has purchased a mobile photon-counting CT scanner from MARS Bioimaging to support ...

Time May 20, 2026
arrow
Feature | Enterprise Imaging | Kyle Hardner

For radiology departments, the imbalance between surging imaging volume and a shortage of trained radiologists is taking ...

Time May 20, 2026
arrow
News | Interventional Radiology

May 12, 2026 — Siemens Healthineers has received clearance from the Food and Drug Administration for six new systems in ...

Time May 12, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

May 11, 2026 – At the International Society for Magnetic Resonance in Medicine (ISMRM) 2026 Annual Meeting, GE ...

Time May 11, 2026
arrow
News | FDA

May 6, 2026 — Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer ...

Time May 07, 2026
arrow
Subscribe Now